Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.52 - $1.05 $1,241 - $2,506
-2,387 Reduced 31.01%
5,311 $4,000
Q4 2023

Feb 13, 2024

SELL
$0.6 - $1.65 $1,573 - $4,326
-2,622 Reduced 25.41%
7,698 $5,000
Q3 2023

Nov 14, 2023

SELL
$1.67 - $3.33 $8,747 - $17,442
-5,238 Reduced 33.67%
10,320 $17,000
Q2 2023

Aug 21, 2023

SELL
$2.83 - $4.94 $116,655 - $203,631
-41,221 Reduced 72.6%
15,558 $44,000
Q1 2023

May 09, 2023

SELL
$4.89 - $12.27 $3,711 - $9,312
-759 Reduced 1.32%
56,779 $278,000
Q4 2022

Feb 14, 2023

BUY
$8.88 - $12.77 $5,869 - $8,440
661 Added 1.16%
57,538 $617,000
Q3 2022

Nov 18, 2022

SELL
$8.24 - $12.56 $4,185 - $6,380
-508 Reduced 0.89%
56,877 $532,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $13.84 $6,943 - $12,898
932 Added 1.65%
57,385 $524,000
Q1 2022

May 16, 2022

SELL
$9.94 - $12.65 $13,727 - $17,469
-1,381 Reduced 2.39%
56,453 $686,000
Q4 2021

Feb 15, 2022

BUY
$11.99 - $18.14 $12,793 - $19,355
1,067 Added 1.88%
57,834 $704,000
Q3 2021

Nov 15, 2021

SELL
$11.55 - $16.06 $51,894 - $72,157
-4,493 Reduced 7.33%
56,767 $877,000
Q2 2021

Aug 16, 2021

SELL
$12.38 - $29.19 $11,265 - $26,562
-910 Reduced 1.46%
61,260 $874,000
Q3 2020

Nov 17, 2020

BUY
$12.34 - $17.92 $12,191 - $17,704
988 Added 1.61%
62,170 $791,000
Q2 2020

Aug 17, 2020

BUY
$12.39 - $17.33 $12,897 - $18,040
1,041 Added 1.73%
61,182 $1.05 Million
Q1 2020

May 13, 2020

SELL
$9.12 - $17.78 $6,192 - $12,072
-679 Reduced 1.12%
60,141 $794,000
Q4 2019

Feb 14, 2020

SELL
$16.11 - $25.98 $19,799 - $31,929
-1,229 Reduced 1.98%
60,820 $980,000
Q3 2019

Nov 15, 2019

BUY
$18.28 - $26.91 $174,519 - $256,909
9,547 Added 18.18%
62,049 $1.13 Million
Q2 2019

Aug 14, 2019

BUY
$17.68 - $21.57 $46,410 - $56,621
2,625 Added 5.26%
52,502 $1.13 Million
Q1 2019

May 09, 2019

SELL
$14.41 - $19.64 $16,485 - $22,468
-1,144 Reduced 2.24%
49,877 $979,000
Q4 2018

Feb 13, 2019

BUY
$12.45 - $23.47 $14,753 - $27,811
1,185 Added 2.38%
51,021 $663,000
Q3 2018

Nov 14, 2018

BUY
$17.57 - $23.95 $146,621 - $199,862
8,345 Added 20.11%
49,836 $1.19 Million
Q2 2018

Aug 14, 2018

BUY
$11.6 - $19.27 $11,785 - $19,578
1,016 Added 2.51%
41,491 $795,000
Q1 2018

May 15, 2018

SELL
$11.77 - $16.08 $19,349 - $26,435
-1,644 Reduced 3.9%
40,475 $501,000
Q4 2017

Feb 14, 2018

SELL
$11.86 - $14.08 $13,994 - $16,614
-1,180 Reduced 2.73%
42,119 $516,000
Q3 2017

Nov 13, 2017

BUY
$12.6 - $16.34 $545,567 - $707,505
43,299
43,299 $593,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.